Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma

European Journal of Internal Medicine

Volumn 25, Issue 3, 2014, Pages 296-302

  Markovic, Olivera ^a,d   Popovic, Lazar ^b,e   Marisavljevic, Dragomir ^a,d   Jovanovic, Darjana ^b,e   Filipovic, Branka ^a,d   Stanisavljevic, Dejana ^c,d   Matovina Brko, Gorana ^b,e   Hajder, Jelena ^a   Matkovic, Tatjana ^a   Živkovic, Radmila ^a   Stanisavljevic, Natasa ^a   Todorović, Milena ^c,d   Petrovic, Dragana ^a   Mihaljevic, Biljana ^c,d  

^a University Clinical Hospital Center Bezanijska Kosa   (Serbia)

^b Institute of Oncology   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Absolute lymphocyte and monocyte counts; ALC AMC prognostic score; ALC AMC ratio; Diffuse large B cell lymphoma

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABSOLUTE LYMPHOCYTE COUNT; ABSOLUTE MONOCYTE COUNT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; INTERNATIONAL PROGNOSTIC INDEX; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; LYMPHOCYTE COUNT ABSOLUTE MONOCYTE COUNT PROGNOSTIC SCORE; LYMPHOCYTE COUNT ABSOLUTE MONOCYTE COUNT RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT; BLOOD; LEUKOCYTE COUNT; MORTALITY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84896400340     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.01.019     Document Type: Article

References (32)

1. B. Coiffier State-of-the-art therapeutics: diffuse large B-cell lymphoma J Clin Oncol 23 2005 6387 6393
2. G. Lenz, G. Wright, S.S. Dave, W. Xiao, J. Powell, and H. Zhao et al. Lymphoma/Leukemia Molecular Profiling Project. Stromal gene signature in large B cell lymphomas N Engl J Med 22 2008 2313 2323
3. M.A. Shipp, K.N. Ross, P. Tamayo, A.P. Weng, J.L. Kutok, and R.C. Aguiar et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Nat Med 8 2002 68 74
4. S.M. Ansell, M. Stenson, T.M. Habermann, D.F. Jelinek, and T.E. Witzig Cd4 + T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome Ansell J Clin Oncol 19 2001 720 726
5. M. Siddiqui, K. Ristow, S.N. Markovic, T.E. Witzig, T.M. Habermann, and J.P. Colgan et al. Absolute lymphocyte count predicts overall survival in follicular lymphomas Br J Haematol 134 2006 596 601
6. D.H. Kim, J.H. Baek, Y.S. Chae, Y.K. Kim, H.J. Kim, and Y.H. Park et al. Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma Leukemia 21 2007 2227 2230
7. L.F. Porrata, M.A. Gertz, D.J. Inwards, M.R. Litzow, M.Q. Lacy, and A. Tefferi et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma Blood 98 2001 579 585
8. L.F. Porrata, K. Ristow, J.P. Colgan, T.M. Habermann, T.E. Witzig, and D.J. Inwards et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma Haematologica 97 2012 262 269
9. M.C. Cox, I. Nofroni, L. Ruco, R. Amodeo, A. Ferrari, and G. La Verde et al. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma Leuk Lymphoma 49 2008 1745 1751
10. S.H. Swerdlow, E. Campo, and N.L. Harris et al. WHO classification of tumours of haematopoietic and lymphoid tissues ed 4th 2008 IARC Press Lyon, France
11. E.S. Jaffe Pathology & genetics: tumours of haematopoietic and lymphoid tissues WHO classification of tumours, pathology and genetics series 3 2001 IARC Press
12. A. Rambaldi, C. Boschini, G. Gritti, F. Delaini, E. Oldani, and A. Rossi et al. The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy Am J Hematol 88 12 2013 1062 1067
13. Z.M. Li, J.J. Huang, Y. Xia, J. Sun, Y. Huang, and Y. Wang et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP PLoS One 7 2012 e41658
14. R.A. Wilcox, K. Ristow, and T.M. Habermann et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma Leukemia 25 2011 1502 1509
15. T.A. Lister, D. Crowther, S.B. Sutcliffe, E. Glatstein, G.P. Canellos, and R.C. Young et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Costwolds meeting J Clin Oncol 7 1989 1630 1636
16. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
17. C.P. Hans, D.D. Weisenburger, and T.C. Greiner et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 2004 275 282
18. B.D. Cheson, B. Pfistner, M.E. Juweid, R.D. Gascoyne, L. Specht, and S.J. Horning et al. Revised response criteria for malignant lymphoma J Clin Oncol 25 2007 579 586
19. H. Tran, J. Nourse, S. Hall, M. Green, L. Griffiths, and M.K. Gandhi Immunodeficiency-associated lymphomas Blood Rev 22 2008 261 281
20. L. Shivakumar, and S. Ansell Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies Clin Lymphoma Myeloma 7 2006 106 108
21. A.J. Novak, D.M. Grote, M. Stenson, S.C. Ziesmer, T.E. Witzig, and T.M. Habermann et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome Blood 104 2004 2247 2253
22. A.E. Dirkx, M.G. Oude Egbrink, J. Wagstaff, and A.W. Griffioen Monocyte/macrophage infiltration in tumors: modulators of angiogenesis J Leukoc Biol 80 2006 1183 1196 [Epub 2006 Sep 22. Review]
23. R.A. Wilcox, D.A. Wada, S.C. Ziesmer, S.F. Elsawa, N.I. Comfere, and A.B. Dietz et al. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells Blood 114 2009 2936 2944
24. H. Schmidt, L. Bastholt, P. Geertsen, I.J. Christensen, S. Larsen, and J. Gehl et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model Br J Cancer 93 2005 273 278
25. I. Ray-Coquard, C. Cropet, and M. Van Glabbeke et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas and lymphomas Cancer Res 69 2009 5358 5391
26. Y.W. Koh, H.J. Kang, C. Park, D.H. Yoon, S. Kim, and C. Suh et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages Oncologist 17 2012 871 880
27. C.L. Jeune, S. Bertoli, M. Elhamri, F. Vergey, C. Borel, and F. Huguet et al. Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia Leuk Lymphoma 2013 [Epub ahead of print]
28. M.K. Song, J.S. Chung, Y.M. Seol, S.G. Kim, H.J. Shin, and Y.J. Choi et al. Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy Ann Oncol 21 2010 140 144
29. J. Feng, Z. Wang, X. Guo, Y. Chen, Y. Cheng, and Y. Tang Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis Int J Hematol 95 2012 143 148
30. A. Plonquet, C. Haioun, J.P. Jais, A.L. Debard, G. Salles, and M.C. Bene et al. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma Ann Oncol 18 2007 1209 1215
31. N. Batty, E. Ghonimi, L. Feng, L. Fayad, A. Younes, and M.A. Rodriguez The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP Clin Lymphoma Myeloma Leuk 13 2013 15 18
32. K. Aoki, S. Tabata, N. Yonetani, A. Matsushita, and T. Ishikawa The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era Acta Haematol 130 2013 242 246 [Epub ahead of print]